Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2010, Article ID 206132, 5 pages
http://dx.doi.org/10.1155/2010/206132
Case Report

Short-Term Bisphosphonate Therapy Could Ameliorate Osteonecrosis: A Complication in Childhood Hematologic Malignancies

1Pediatric Endocrinology and Adolescence, Department of Pediatrics, Hospital-University of Padova, 35128 Padova, Italy
2Hemo/Oncology, Department of Pediatrics, Hospital-University of Padova, 35128 Padova, Italy
3Pediatric Radiology, Department of Pediatrics, Hospital-University of Padova, 35128 Padova, Italy
4Pharmacy, Veneto Oncology Institute - IRCCS, 35128 Padova, Italy

Received 6 March 2010; Accepted 25 April 2010

Academic Editor: Werner Rabitsch

Copyright © 2010 N. A. Greggio et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. T. Chollet, L. Britton, M. D. Neel, M. M. Hudson, and S. C. Kaste, “Childhood cancer survivors: an at-risk cohort for ankle osteonecrosis,” Clinical Orthopaedics and Related Research, no. 430, pp. 149–155, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Messina, E. Calore, S. Cesaro, and L. Zanesco, “Osteonecrosi asettica in ematologia pediatrica,” in Osteopatie ediatriche emergenti. Fisiopatologia, clinica e terapia, N. A. Greggio, F. Rigon, and F. Zacchello, Eds., pp. 247–254, Piccin, Padova, Italy, 2003. View at Google Scholar
  3. E. Y. Cheng, I. Thongtrangan, A. Laorr, and K. J. Saleh, “Spontaneous resolution of osteonecrosis of the femoral head,” Journal of Bone and Joint Surgery. Series A, vol. 86, no. 12, pp. 2594–2599, 2004. View at Google Scholar · View at Scopus
  4. W. H. Harris, “Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation,” Journal of Bone and Joint Surgery. Series A, vol. 51, no. 4, pp. 737–755, 1969. View at Google Scholar
  5. R. D. Barr and A. Sala, “Osteonecrosis in children and adolescents with cancer,” Pediatric Blood and Cancer, vol. 50, no. 2, pp. 483–485, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. G. Socié, J. Y. Cahn, and J. Y. Cahn, “Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Societe Francaise de Greffe de Moelle (SFGM),” British Journal of Haematology, vol. 97, no. 4, pp. 865–870, 1997. View at Google Scholar · View at Scopus
  7. A. E. Ojala, E. Pääkkö, F. P. Lanning, and M. Lanning, “Osteonecrosis during the treatment of childhood acute lymphoblastic leukemia: a prospective MRI study,” Medical and Pediatric Oncology, vol. 32, no. 1, pp. 11–17, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. W. Högler, G. Wehl, T. van Staa, B. Meister, A. Klein-Franke, and G. Kropshofer, “Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the general practice research database,” Pediatric Blood and Cancer, vol. 48, no. 1, pp. 21–27, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. B. Bürger, R. Beier, M. Zimmermann, J. D. Beck, A. Reiter, and M. Schrappe, “Osteonecrosis: a treatment related toxicity in childhood Acute Lymphoblastic Leukemia (ALL)—experiences from trial ALL-BFM 95,” Pediatric Blood and Cancer, vol. 44, no. 3, pp. 220–225, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. L. A. Mattano Jr., H. N. Sather, M. E. Trigg, and J. B. Nachman, “Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group,” Journal of Clinical Oncology, vol. 18, no. 18, pp. 3262–3272, 2000. View at Google Scholar · View at Scopus
  11. P. S. Gaynon and R. H. Lustig, “The use of glucocorticoids in acute lymphoblastic leukemia of childhood. Molecular, cellular, and clinical considerations,” Journal of Pediatric Hematology/Oncology, vol. 17, no. 1, pp. 1–12, 1995. View at Google Scholar · View at Scopus
  12. P. S. Gaynon, P. G. Steinherz, and P. G. Steinherz, “Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group study CCG-106,” Journal of Clinical Oncology, vol. 11, no. 11, pp. 2234–2242, 1993. View at Google Scholar · View at Scopus
  13. L. Axelrod, “Glucocorticoid therapy,” Medicine, vol. 55, no. 1, pp. 39–65, 1976. View at Google Scholar · View at Scopus
  14. C. Israelite, C. L. Nelson, C. F. Ziarani, J. A. Abboud, J. Landa, and M. E. Steinberg, “Bilateral core decompression for osteonecrosis of the femoral head,” Clinical Orthopaedics and Related Research, no. 441, pp. 285–290, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. E. J. Karimova, S. N. Rai, J. Wu, L. Britton, S. C. Kaste, and M. D. Neel, “Femoral resurfacing in young patients with hematologic cancer and osteonecrosis,” Clinical Orthopaedics and Related Research, vol. 466, no. 12, pp. 3044–3050, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. S. Y. Wei, A. N. Esmail, N. Bunin, and J. P. Dormans, “Avascular necrosis in children with acute lymphoblastic leukemia,” Journal of Pediatric Orthopaedics, vol. 20, no. 3, pp. 331–335, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Trancik, E. Lunceford, and D. Strum, “The effect of electrical stimulation on osteonecrosis of the femoral head,” Clinical Orthopaedics and Related Research, no. 256, pp. 120–124, 1990. View at Google Scholar · View at Scopus
  18. M. E. Steinberg, C. T. Brighton, R. E. Bands, and K. M. Hartman, “Capacitive coupling as an adjunctive treatment for avascular necrosis,” Clinical Orthopaedics and Related Research, no. 261, pp. 11–18, 1990. View at Google Scholar · View at Scopus
  19. B. Bernbeck, A. Christaras, and A. Christaras, “Bone marrow oedema and aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukaemia or Non-Hodgkin-lymphoma treated with hyperbaric-oxygen-therapy (HBO): an approach to cure? BME/AON and hyperbaric oxygen therapy as a treatment modality,” Klinische Padiatrie, vol. 216, no. 6, pp. 370–378, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. S. Agarwala, D. Jain, V. R. Joshi, and A. Sule, “Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study,” Rheumatology, vol. 44, no. 3, pp. 352–359, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. S. Mpofu, “Erratum: Rheumatology (2005) vol. 44(3) 274–401,” Rheumatology, vol. 44, no. 4, p. 569, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. K.-A. Lai, W.-J. Shen, C.-Y. Yang, C.-J. Shao, J.-T. Hsu, and R.-M. Lin, “The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis: a randomized clinical study,” Journal of Bone and Joint Surgery. Series A, vol. 87, no. 10, pp. 2155–2159, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. T. Nish II, N. Sugano, H. Miki, J. Hashimoto, and H. Yoshikawa, “Does alendronate prevent collapse in osteonecrosis of the femoral head?” Clinical Orthopaedics and Related Research, no. 443, pp. 273–279, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. H. Fleisch, “Bisphosphonates: mechanisms of action,” Endocrine Reviews, vol. 19, no. 1, pp. 80–100, 1998. View at Google Scholar · View at Scopus
  25. H. Fleisch, Bisphosphonates in Bone Diseases. From the Laboratory to the Patient, Academic Press, San Diego, Calif, USA, 2000.
  26. R. E. Coleman, “Treatment of tumor induced osteolysis and prevention of skeletal-related events in patients with bone metastases,” in Tumor Bone Diseases and Osteoporosis in Cancer Patients: Pathophysiology, Diagnosis and Therapy, J.-J. Body, Ed., pp. 409–434, Dekker, Basel, Switzerland, 1999. View at Google Scholar
  27. R. S. Kotecha, N. Powers, S.-J. Lee, K. J. Murray, T. Carter, and C. Cole, “Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL),” Pediatric Blood and Cancer, vol. 54, no. 7, pp. 934–940, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. A. N. Lteif and D. Zimmerman, “Bisphosphonates for treatment of childhood hypercalcemia,” Pediatrics, vol. 102, no. 4 I, pp. 990–993, 1998. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Schmid, D. Stachel, C. Schön, M. Bauer, and R. J. Haas, “Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children,” Klinische Padiatrie, vol. 213, no. 1, pp. 30–34, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. B. M. Kuehn, “Long-term risks of bisphosphonates probed,” Journal of the American Medical Association, vol. 301, no. 7, pp. 710–711, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. R. E. Coleman, “Risks and benefits of bisphosphonates,” British Journal of Cancer, vol. 98, no. 11, pp. 1736–1740, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. E. B. Goldbloom, E. A. Cummings, and M. Yhap, “Osteoporosis at presentation of childhood ALL: management with pamidronate,” Pediatric Hematology and Oncology, vol. 22, no. 7, pp. 543–550, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. A. Sala, L. A. Mattano Jr., and R. D. Barr, “Osteonecrosis in children and adolescents with cancer—an adverse effect of systemic therapy,” European Journal of Cancer, vol. 43, no. 4, pp. 683–689, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus